These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparative survival analysis of adjuvant therapy with iodine-131-labeled lipiodol to hepatic resection of primary hepatocellular carcinoma: a meta-analysis. Gong L; Shi L; Sun J; Yuan WS; Chen JF; Liu P; Gong F; Dong JH Nucl Med Commun; 2014 May; 35(5):484-92. PubMed ID: 24492679 [TBL] [Abstract][Full Text] [Related]
6. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study. Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884 [TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of adjuvant i(131) lipiodol after excision of hepatocellular carcinoma. Furtado R; Crawford M; Sandroussi C Ann Surg Oncol; 2014 Aug; 21(8):2700-7. PubMed ID: 24743904 [TBL] [Abstract][Full Text] [Related]
8. On developing a pragmatic strategy for clinical trials: A case study of hepatocellular carcinoma. Gandhi M; Tan SB; Chung Yaw Fui A; Machin D Contemp Clin Trials; 2015 Jul; 43():252-9. PubMed ID: 26111924 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lau WY; Leung TW; Ho SK; Chan M; Machin D; Lau J; Chan AT; Yeo W; Mok TS; Yu SC; Leung NW; Johnson PJ Lancet; 1999 Mar; 353(9155):797-801. PubMed ID: 10459961 [TBL] [Abstract][Full Text] [Related]
10. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates. Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301 [TBL] [Abstract][Full Text] [Related]
11. Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experience. Lintia-Gaultier A; Perret C; Ansquer C; Eugène T; Kraeber-Bodéré F; Frampas E Nucl Med Commun; 2013 Jul; 34(7):674-81. PubMed ID: 23587835 [TBL] [Abstract][Full Text] [Related]
13. Survival and prognostic factors after adjuvant Olesinski J; Mithieux F; Guillaud O; Hilleret MN; Lombard-Bohas C; Henry L; Boillot O; Walter T; Partensky C; Paliard P; Valette PJ; Vuillez JP; Borson-Chazot F; Scoazec JY; Dumortier J Ann Nucl Med; 2017 Jun; 31(5):379-389. PubMed ID: 28342103 [TBL] [Abstract][Full Text] [Related]
14. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study. Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004 [TBL] [Abstract][Full Text] [Related]
15. Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence. Nishikawa H; Osaki Y; Kita R; Kimura T; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Saito S; Nasu A Int J Oncol; 2012 Sep; 41(3):903-9. PubMed ID: 22692851 [TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial to compare the dose of adjuvant chemotherapy after curative resection of hepatocellular carcinoma. Kwok PC; Lam TW; Lam PW; Tang KW; Chan SC; Hwang JS; Cheung MT; Tang DL; Chung TK; Chia NH; Wong WK; Chan MK; Lo HY; Lam WM J Gastroenterol Hepatol; 2003 Apr; 18(4):450-5. PubMed ID: 12653895 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant I-131 Lipiodol After Resection or Radiofrequency Ablation for Hepatocellular Carcinoma. Schwarz L; Bubenheim M; Gardin I; Huet E; Riachi G; Clavier E; Goria O; Vera P; Scotté M World J Surg; 2016 Aug; 40(8):1941-50. PubMed ID: 27098539 [TBL] [Abstract][Full Text] [Related]
18. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma. Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022 [TBL] [Abstract][Full Text] [Related]
19. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis. Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up. Boucher E; Bouguen G; Garin E; Guillygomarch A; Boudjema K; Raoul JL J Nucl Med; 2008 Mar; 49(3):362-6. PubMed ID: 18287267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]